{"gene":"POLE","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2012,"finding":"Germline heterozygous mutations in the proofreading (exonuclease) domain of POLE (p.Leu424Val) cause defective correction of mispaired bases inserted during DNA replication, leading to base substitution hypermutation in tumors. Yeast functional assays confirmed that these mutations impair exonuclease proofreading activity.","method":"Whole-genome sequencing, linkage/association analysis, yeast functional assays","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — yeast functional assays directly confirmed loss of proofreading activity; independently replicated across multiple families and labs","pmids":["23263490"],"is_preprint":false},{"year":2015,"finding":"Somatic POLE exonuclease domain mutations cause an ultramutated phenotype in endometrial cancer characterized by C>A transversions and T>G substitutions, with microsatellite-stable tumors, resulting from defective proofreading of mispaired bases during DNA replication.","method":"Whole-exome sequencing, mutational signature analysis, genomic characterization of TCGA cohort","journal":"Clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — large genomic cohort with defined mutational signatures, single lab analysis but confirmed in independent TCGA dataset","pmids":["25878334"],"is_preprint":false},{"year":2014,"finding":"POLE exonuclease domain mutations at position p.Asn363Lys (located in the proofreading exonuclease domain) are directly involved in DNA binding; theoretical modeling predicted a profound effect on substrate binding capability and more severe impairment of catalytic activity compared to the p.Leu424Val mutation.","method":"Germline sequencing, in silico structural prediction, clinical phenotyping","journal":"International journal of oncology","confidence":"Low","confidence_rationale":"Tier 4 / Weak — mechanistic inference based primarily on computational prediction; no direct biochemical assay performed in this paper","pmids":["24788313"],"is_preprint":false},{"year":2015,"finding":"POLE exonuclease domain mutations generate an enriched repertoire of antigenic neoepitopes, which drives a robust intratumoral cytotoxic T-cell response (increased CD8+ TILs, upregulation of T-bet, Eomes, IFNG, PRF, granzyme B), explaining the favorable prognosis of POLE-ultramutated endometrial cancers.","method":"Immunohistochemistry for CD8+ TIL quantification, RNAseq analysis (TCGA), in silico neoepitope prediction","journal":"Clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — orthogonal methods (IHC, RNAseq, in silico neoepitope analysis) in single cohort with TCGA confirmation","pmids":["25878334"],"is_preprint":false},{"year":2020,"finding":"Different POLE cancer mutant alleles drive distinct mutation spectra through differing degrees of replication fidelity impairment; unlike an exonuclease active-site mutant, POLE cancer mutants readily drive signature mutagenesis even in the presence of functional mismatch repair (MMR). The identity, abundance, and MMR status of the mutant allele shape the final mutation spectrum.","method":"CRISPR-Cas9 engineering of human cell lines expressing POLE tumor variants, whole-exome sequencing after defined population doublings","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct CRISPR-engineered cell lines with quantitative mutation accumulation analysis; multiple POLE alleles compared with and without MMR","pmids":["32497495"],"is_preprint":false},{"year":2015,"finding":"A POLE germline mutation p.Tyr458Phe, located in the active site of the exonuclease domain, affects a residue important for exonuclease activity. Functional assays in S. pombe demonstrated increased DNA mutation rate comparable to a Pol ε mutant lacking exonuclease activity entirely.","method":"Exome sequencing, S. pombe functional mutation rate assays","journal":"Familial cancer","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vivo yeast functional assay directly measuring mutation rate, but single lab, single variant","pmids":["25860647"],"is_preprint":false},{"year":2015,"finding":"A POLE germline mutation p.Trp347Cys in the exonuclease domain leads to an increased DNA mutation rate in S. pombe functional assays, comparable to that seen with a Pol ε mutant with no exonuclease activity.","method":"S. pombe functional assays measuring mutation rate","journal":"Familial cancer","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct yeast functional assay, single lab, single variant tested","pmids":["26251183"],"is_preprint":false},{"year":2017,"finding":"A POLE variant c.1420G>A (p.Val474Ile) outside the canonical exonuclease domain was shown by functional assays in Schizosaccharomyces pombe to impair proofreading activity, broadening the spectrum of POLE changes that can lead to mutator phenotype.","method":"S. pombe functional mutation rate assays, bioinformatics prediction","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct yeast functional assay performed, single lab, single variant","pmids":["28423643"],"is_preprint":false},{"year":2022,"finding":"Murine syngeneic tumors harboring functional Pole mutations displayed enhanced antitumor immunity and sensitivity to immune checkpoint blockade. Pathogenic POLE/POLD1 mutations generate neoantigens with increased hydrophobicity at TCR-contact residues, potentially facilitating T-cell recognition. The spectrum of mutational signatures (not merely mutation presence) correlates with the biochemical features of neoantigens and predicts ICB response.","method":"Murine syngeneic tumor models with Pole mutations, mutational signature analysis, neoantigen biochemical feature analysis, clinical ICB outcome correlation","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — orthogonal experimental (mouse tumor models) and correlative patient data with mechanistic neoantigen analysis; replicated across cohorts","pmids":["35817971"],"is_preprint":false},{"year":2015,"finding":"POLE exonuclease domain mutation (ultramutated EC) primary cell lines are significantly more resistant to platinum-based chemotherapy in vitro compared to POLE wild-type EC cell lines, suggesting that favorable prognosis of POLE-mutated tumors is not secondary to chemosensitivity but to enhanced immunogenicity.","method":"Primary tumor cell line establishment, in vitro platinum drug sensitivity assays","journal":"Gynecologic oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vitro drug sensitivity assay in primary cell lines, single lab","pmids":["27894751"],"is_preprint":false},{"year":2015,"finding":"A patient with POLE1 deficiency (homozygous splice variant c.4444+3A>G in the POLE1 gene encoding the catalytic subunit of DNA polymerase epsilon) manifested a severe chromosome instability syndrome with growth retardation, microcephaly, developmental delay, immune deficiency, and myelodysplasia, demonstrating that loss of POLE1 catalytic function causes a DNA instability phenotype in humans.","method":"Exome sequencing, clinical phenotyping of POLE1-deficient patient","journal":"BMC medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — human loss-of-function variant with defined clinical phenotype, single case report","pmids":["25948378"],"is_preprint":false},{"year":2020,"finding":"Loss-of-function and outside-exonuclease-domain variants in POLE are likely not pathogenic for polymerase proofreading-associated cancer syndrome, whereas missense variants within the exonuclease domain that impair proofreading are the relevant pathogenic class. This was supported by cosegregation, case-control studies, and yeast-based functional assays.","method":"Multigene panel sequencing, yeast functional assays, cosegregation and case-control studies","journal":"Genetics in medicine","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — yeast functional assays plus clinical genetic evidence; multi-variant analysis in large cohort","pmids":["32792570"],"is_preprint":false},{"year":2020,"finding":"Pathogenic POLE exonuclease domain mutations (EDMs) produce a characteristic genomic signature: C>A substitutions >20%, T>G substitutions >4%, C>G substitutions <0.6%, indels <5%, and TMB >100 mut/Mb. Co-existence of pathogenic POLE EDM with MSI-H still produces POLE-characteristic genomic alterations, demonstrating that the POLE proofreading defect dominates the mutational phenotype.","method":"Whole-exome sequencing, genomic signature analysis, mutational burden analysis (TCGA cohort and independent cohort)","journal":"The Journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic genomic characterization of 82 ECs with multiple orthogonal genomic metrics; confirmed in pooled analysis","pmids":["31829442"],"is_preprint":false}],"current_model":"POLE (DNA polymerase epsilon catalytic subunit, POLE1) encodes the catalytic and proofreading subunit of DNA polymerase epsilon; missense mutations within its exonuclease (proofreading) domain impair correction of mispaired bases during DNA replication, causing extreme base-substitution hypermutation with a characteristic mutational signature (C>A, T>G enrichment), which in turn generates abundant neoantigens that elicit robust cytotoxic T-cell responses and sensitize tumors to immune checkpoint blockade, while different mutant alleles vary in their degree of replication fidelity impairment and interact with mismatch repair status to shape the final mutation burden and spectrum."},"narrative":{"mechanistic_narrative":"POLE encodes the catalytic and proofreading subunit of DNA polymerase epsilon, whose exonuclease (proofreading) domain corrects mispaired bases inserted during DNA replication; germline and somatic missense mutations in this domain impair proofreading and produce base-substitution hypermutation in tumors [PMID:23263490, PMID:25878334]. Yeast functional assays directly confirm that such exonuclease-domain variants (e.g., p.Leu424Val, p.Trp347Cys, p.Tyr458Phe) raise mutation rates to levels comparable with complete loss of exonuclease activity, while non-exonuclease and loss-of-function variants do not cause the proofreading-associated cancer phenotype [PMID:23263490, PMID:25860647, PMID:26251183, PMID:32792570]. The resulting genomic signature is highly characteristic — enrichment of C>A transversions and T>G substitutions with very high tumor mutational burden — and this proofreading defect dominates the mutational phenotype even when mismatch repair is concurrently defective [PMID:25878334, PMID:32497495, PMID:31829442]. Different POLE mutant alleles drive distinct mutation spectra according to their degree of fidelity impairment, and cancer-associated mutants generate signature mutagenesis even in the presence of functional mismatch repair [PMID:32497495]. The hypermutator phenotype generates an enriched repertoire of antigenic neoepitopes that elicits a robust intratumoral cytotoxic CD8+ T-cell response and confers sensitivity to immune checkpoint blockade [PMID:25878334, PMID:35817971]. Complete loss of POLE catalytic function causes a distinct chromosome-instability syndrome with growth retardation, microcephaly, immune deficiency, and myelodysplasia [PMID:25948378].","teleology":[{"year":2012,"claim":"Established that germline mutations in the POLE proofreading domain are causal for base-substitution hypermutation, linking a specific molecular defect to a cancer-predisposition phenotype.","evidence":"Whole-genome sequencing with linkage/association analysis and yeast functional assays of p.Leu424Val","pmids":["23263490"],"confidence":"High","gaps":["Did not resolve the quantitative mutation rate of individual alleles","Did not address somatic versus germline contribution to tumor burden"]},{"year":2014,"claim":"Predicted that distinct exonuclease-domain residues contribute to DNA/substrate binding and that different variants impair catalysis to differing degrees.","evidence":"Germline sequencing with in silico structural modeling of p.Asn363Lys","pmids":["24788313"],"confidence":"Low","gaps":["No direct biochemical assay performed; computational prediction only","Predicted differential severity not experimentally validated"]},{"year":2015,"claim":"Defined the somatic ultramutated genomic phenotype of POLE-mutant endometrial cancer and connected it to enhanced immunogenicity and favorable prognosis via neoepitope-driven cytotoxic T-cell responses.","evidence":"Whole-exome and mutational signature analysis, IHC for CD8+ TILs, and RNAseq in a TCGA cohort with in silico neoepitope prediction","pmids":["25878334"],"confidence":"Medium","gaps":["Neoepitope immunogenicity inferred in silico, not functionally validated","Causal link between T-cell response and outcome correlative"]},{"year":2015,"claim":"Directly measured that specific exonuclease-domain germline variants (p.Tyr458Phe, p.Trp347Cys) raise mutation rates to levels comparable to complete exonuclease loss, validating their pathogenicity functionally.","evidence":"S. pombe functional mutation-rate assays of individual variants","pmids":["25860647","26251183"],"confidence":"Medium","gaps":["Single-variant, single-lab assays","Yeast mutation rate may not fully reproduce human tumor spectrum"]},{"year":2015,"claim":"Demonstrated that POLE-mutant tumor cells are resistant to platinum chemotherapy, establishing that favorable prognosis derives from immunogenicity rather than chemosensitivity.","evidence":"Primary tumor cell line establishment with in vitro platinum sensitivity assays","pmids":["27894751"],"confidence":"Medium","gaps":["Single-lab in vitro assay","Did not test in vivo chemotherapy response"]},{"year":2015,"claim":"Showed that complete loss of POLE catalytic function in humans causes a chromosome-instability/immunodeficiency syndrome distinct from the proofreading-associated cancer phenotype.","evidence":"Exome sequencing and clinical phenotyping of a homozygous splice-variant patient","pmids":["25948378"],"confidence":"Medium","gaps":["Single case report","Mechanistic basis of multisystem phenotype not dissected"]},{"year":2017,"claim":"Extended the pathogenic variant spectrum by showing a variant outside the canonical exonuclease domain can also impair proofreading.","evidence":"S. pombe functional mutation-rate assays of p.Val474Ile","pmids":["28423643"],"confidence":"Medium","gaps":["Single variant, single lab","Structural basis of proofreading impairment outside the domain unresolved"]},{"year":2020,"claim":"Resolved allele-specific behavior, showing that cancer POLE mutants drive signature mutagenesis even with functional mismatch repair, and that allele identity, abundance, and MMR status shape the final spectrum.","evidence":"CRISPR-Cas9 engineering of human cell lines expressing POLE tumor variants with whole-exome sequencing after defined population doublings","pmids":["32497495"],"confidence":"High","gaps":["Limited set of alleles tested","Quantitative contribution of each factor to clinical spectrum not modeled"]},{"year":2020,"claim":"Clarified which variant classes are pathogenic, establishing that exonuclease-domain missense variants impairing proofreading—not loss-of-function or out-of-domain variants—drive the cancer syndrome.","evidence":"Multigene panel sequencing with yeast functional assays, cosegregation and case-control studies","pmids":["32792570"],"confidence":"Medium","gaps":["Some intermediate variants of uncertain significance remain unclassified"]},{"year":2020,"claim":"Quantified a robust diagnostic genomic signature and showed the POLE proofreading defect dominates even when co-occurring with MSI-H.","evidence":"Whole-exome and genomic signature/TMB analysis of endometrial cancer cohorts","pmids":["31829442"],"confidence":"Medium","gaps":["Thresholds derived from limited cohort","Generalizability across tumor types not fully tested"]},{"year":2022,"claim":"Provided in vivo causal evidence that POLE-driven mutagenesis enhances antitumor immunity and ICB sensitivity, and linked neoantigen biochemical features (hydrophobicity at TCR-contact residues) and signature spectrum to immune response.","evidence":"Murine syngeneic tumor models with Pole mutations, neoantigen biochemical feature analysis, and clinical ICB outcome correlation","pmids":["35817971"],"confidence":"High","gaps":["Causal contribution of specific neoantigens to ICB response not isolated","Predictive value of signature spectrum requires prospective validation"]},{"year":null,"claim":"How POLE assembles into and functions within the holoenzyme replication complex, and the structural basis by which individual exonuclease-domain residues control proofreading fidelity, remain uncharacterized in this corpus.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of mutant proofreading defects","Holoenzyme partner interactions not addressed in the timeline"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,4,5,6,7]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,5,6]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2]}],"localization":[],"pathway":[{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[0,4]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[0,11]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,10,12]}],"complexes":["DNA polymerase epsilon"],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q07864","full_name":"DNA polymerase epsilon catalytic subunit A","aliases":["3'-5' exodeoxyribonuclease","DNA polymerase II subunit A"],"length_aa":2286,"mass_kda":261.5,"function":"Catalytic component of the DNA polymerase epsilon complex (PubMed:10801849). Participates in chromosomal DNA replication (By similarity). Required during synthesis of the leading DNA strands at the replication fork, binds at/or near replication origins and moves along DNA with the replication fork (By similarity). Has 3'-5' proofreading exonuclease activity that corrects errors arising during DNA replication (By similarity). Involved in DNA synthesis during DNA repair (PubMed:20227374, PubMed:27573199). Along with DNA polymerase POLD1 and DNA polymerase POLK, has a role in excision repair (NER) synthesis following UV irradiation (PubMed:20227374)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q07864/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/POLE","classification":"Common Essential","n_dependent_lines":1204,"n_total_lines":1208,"dependency_fraction":0.9966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"FKBP5","stoichiometry":0.2},{"gene":"PTGES3","stoichiometry":0.2},{"gene":"SSRP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/POLE","total_profiled":1310},"omim":[{"mim_id":"621558","title":"RETINAL DYSTROPHY, ZEITZ-HAN TYPE; RDZH","url":"https://www.omim.org/entry/621558"},{"mim_id":"621398","title":"CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 100; CFAP100","url":"https://www.omim.org/entry/621398"},{"mim_id":"621371","title":"ENHANCED S-CONE SYNDROME 2; ESCS2","url":"https://www.omim.org/entry/621371"},{"mim_id":"621208","title":"CHROMOSOME 19 OPEN READING FRAME 44; C19ORF44","url":"https://www.omim.org/entry/621208"},{"mim_id":"621033","title":"NUP210-LIKE PROTEIN; NUP210L","url":"https://www.omim.org/entry/621033"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":20.8}],"url":"https://www.proteinatlas.org/search/POLE"},"hgnc":{"alias_symbol":["POLE1"],"prev_symbol":[]},"alphafold":{"accession":"Q07864","domains":[{"cath_id":"3.30.342.10","chopping":"46-197_213-268","consensus_level":"medium","plddt":85.2687,"start":46,"end":268},{"cath_id":"3.30.420.10","chopping":"271-472","consensus_level":"medium","plddt":89.9266,"start":271,"end":472},{"cath_id":"-","chopping":"535-677_736-938","consensus_level":"medium","plddt":89.2848,"start":535,"end":938},{"cath_id":"1.10.132.60","chopping":"960-1168","consensus_level":"medium","plddt":87.1165,"start":960,"end":1168},{"cath_id":"-","chopping":"1487-1650","consensus_level":"high","plddt":85.1515,"start":1487,"end":1650},{"cath_id":"-","chopping":"2152-2195","consensus_level":"medium","plddt":70.5066,"start":2152,"end":2195},{"cath_id":"-","chopping":"2200-2285","consensus_level":"high","plddt":82.7156,"start":2200,"end":2285}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q07864","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q07864-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q07864-F1-predicted_aligned_error_v6.png","plddt_mean":79.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLE","jax_strain_url":"https://www.jax.org/strain/search?query=POLE"},"sequence":{"accession":"Q07864","fasta_url":"https://rest.uniprot.org/uniprotkb/Q07864.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q07864/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q07864"}},"corpus_meta":[{"pmid":"23263490","id":"PMC_23263490","title":"Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23263490","citation_count":777,"is_preprint":false},{"pmid":"31031001","id":"PMC_31031001","title":"Marine DNA Viral Macro- and Microdiversity from Pole to Pole.","date":"2019","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/31031001","citation_count":549,"is_preprint":false},{"pmid":"31829442","id":"PMC_31829442","title":"Interpretation of somatic POLE mutations in endometrial carcinoma.","date":"2020","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31829442","citation_count":340,"is_preprint":false},{"pmid":"27159395","id":"PMC_27159395","title":"Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.","date":"2016","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/27159395","citation_count":317,"is_preprint":false},{"pmid":"8026330","id":"PMC_8026330","title":"Localization of vasa protein to the Drosophila pole plasm is independent of its RNA-binding and helicase activities.","date":"1994","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8026330","citation_count":295,"is_preprint":false},{"pmid":"22327364","id":"PMC_22327364","title":"Chromosome- and spindle-pole-derived signals generate an intrinsic code for spindle position and orientation.","date":"2012","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22327364","citation_count":277,"is_preprint":false},{"pmid":"25878334","id":"PMC_25878334","title":"POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer.","date":"2015","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/25878334","citation_count":262,"is_preprint":false},{"pmid":"18805088","id":"PMC_18805088","title":"A polymeric protein anchors the chromosomal origin/ParB complex at a bacterial cell pole.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18805088","citation_count":256,"is_preprint":false},{"pmid":"23045668","id":"PMC_23045668","title":"Pole-to-pole biogeography of surface and deep marine bacterial communities.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23045668","citation_count":193,"is_preprint":false},{"pmid":"11932022","id":"PMC_11932022","title":"The anterior heart-forming field: voyage to the arterial pole of the heart.","date":"2002","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/11932022","citation_count":193,"is_preprint":false},{"pmid":"23702412","id":"PMC_23702412","title":"Cytoarchitecture, probability maps and functions of the human frontal pole.","date":"2013","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/23702412","citation_count":184,"is_preprint":false},{"pmid":"25394778","id":"PMC_25394778","title":"Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.","date":"2014","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/25394778","citation_count":167,"is_preprint":false},{"pmid":"10459013","id":"PMC_10459013","title":"Sid2p, a spindle pole body kinase that regulates the onset of cytokinesis.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10459013","citation_count":159,"is_preprint":false},{"pmid":"2497990","id":"PMC_2497990","title":"Centrosomes, and not nuclei, initiate pole cell formation in Drosophila embryos.","date":"1989","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2497990","citation_count":155,"is_preprint":false},{"pmid":"12808028","id":"PMC_12808028","title":"RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12808028","citation_count":150,"is_preprint":false},{"pmid":"24345373","id":"PMC_24345373","title":"How do bacteria localize proteins to the cell pole?","date":"2013","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24345373","citation_count":144,"is_preprint":false},{"pmid":"11010907","id":"PMC_11010907","title":"Bacterial activity in South Pole snow.","date":"2000","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11010907","citation_count":144,"is_preprint":false},{"pmid":"7737118","id":"PMC_7737118","title":"Yeast spindle pole body duplication gene MPS1 encodes an essential dual specificity protein kinase.","date":"1995","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7737118","citation_count":139,"is_preprint":false},{"pmid":"23070816","id":"PMC_23070816","title":"A multidomain hub anchors the chromosome segregation and chemotactic machinery to the bacterial pole.","date":"2012","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/23070816","citation_count":138,"is_preprint":false},{"pmid":"24501277","id":"PMC_24501277","title":"New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24501277","citation_count":123,"is_preprint":false},{"pmid":"35143306","id":"PMC_35143306","title":"Mechanism of spindle pole organization and instability in human oocytes.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35143306","citation_count":120,"is_preprint":false},{"pmid":"15339663","id":"PMC_15339663","title":"Cytokinesis monitoring during development; rapid pole-to-pole shuttling of a signaling protein by localized kinase and phosphatase in Caulobacter.","date":"2004","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15339663","citation_count":114,"is_preprint":false},{"pmid":"26648449","id":"PMC_26648449","title":"Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers.","date":"2015","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/26648449","citation_count":107,"is_preprint":false},{"pmid":"32792570","id":"PMC_32792570","title":"Role of POLE and POLD1 in familial cancer.","date":"2020","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32792570","citation_count":103,"is_preprint":false},{"pmid":"23516109","id":"PMC_23516109","title":"Aurora at the pole and equator: overlapping functions of Aurora kinases in the mitotic spindle.","date":"2013","source":"Open biology","url":"https://pubmed.ncbi.nlm.nih.gov/23516109","citation_count":101,"is_preprint":false},{"pmid":"30198841","id":"PMC_30198841","title":"Peptidoglycan precursor synthesis along the sidewall of pole-growing mycobacteria.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30198841","citation_count":100,"is_preprint":false},{"pmid":"26166783","id":"PMC_26166783","title":"Aurora A Kinase Contributes to a Pole-Based Error Correction Pathway.","date":"2015","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/26166783","citation_count":99,"is_preprint":false},{"pmid":"35780178","id":"PMC_35780178","title":"POLE/POLD1 mutation and tumor immunotherapy.","date":"2022","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/35780178","citation_count":97,"is_preprint":false},{"pmid":"16272122","id":"PMC_16272122","title":"Regulated pole-to-pole oscillations of a bacterial gliding motility protein.","date":"2005","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/16272122","citation_count":97,"is_preprint":false},{"pmid":"7774604","id":"PMC_7774604","title":"Cell adhesion to the apical pole of epithelium: a function of cell polarity.","date":"1995","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7774604","citation_count":90,"is_preprint":false},{"pmid":"24778223","id":"PMC_24778223","title":"Bacterial scaffold directs pole-specific centromere segregation.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24778223","citation_count":85,"is_preprint":false},{"pmid":"17028581","id":"PMC_17028581","title":"Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance.","date":"2006","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/17028581","citation_count":85,"is_preprint":false},{"pmid":"30150290","id":"PMC_30150290","title":"Macropinosome formation by tent pole ruffling in macrophages.","date":"2018","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30150290","citation_count":83,"is_preprint":false},{"pmid":"11267871","id":"PMC_11267871","title":"Asymmetric spindle pole localization of yeast Cdc15 kinase links mitotic exit and cytokinesis.","date":"2001","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11267871","citation_count":79,"is_preprint":false},{"pmid":"21865156","id":"PMC_21865156","title":"Biogenesis of the posterior pole is mediated by the exosome/microvesicle protein-sorting pathway.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21865156","citation_count":77,"is_preprint":false},{"pmid":"10744974","id":"PMC_10744974","title":"Phosphorylation and spindle pole body localization of the Cdc15p mitotic regulatory protein kinase in budding yeast.","date":"2000","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/10744974","citation_count":76,"is_preprint":false},{"pmid":"12445269","id":"PMC_12445269","title":"The distal pole complex: a novel membrane domain distal to the immunological synapse.","date":"2002","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/12445269","citation_count":74,"is_preprint":false},{"pmid":"25593304","id":"PMC_25593304","title":"From equator to pole: splitting chromosomes in mitosis and meiosis.","date":"2015","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/25593304","citation_count":71,"is_preprint":false},{"pmid":"20702561","id":"PMC_20702561","title":"Arterial pole progenitors interpret opposing FGF/BMP signals to proliferate or differentiate.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20702561","citation_count":70,"is_preprint":false},{"pmid":"24992682","id":"PMC_24992682","title":"zic-1 Expression in Planarian neoblasts after injury controls anterior pole regeneration.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24992682","citation_count":70,"is_preprint":false},{"pmid":"30917185","id":"PMC_30917185","title":"Phenotype of POLE-mutated endometrial cancer.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30917185","citation_count":68,"is_preprint":false},{"pmid":"25860647","id":"PMC_25860647","title":"A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine.","date":"2015","source":"Familial cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25860647","citation_count":66,"is_preprint":false},{"pmid":"38777726","id":"PMC_38777726","title":"Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer.","date":"2024","source":"Annals of oncology : official journal of the European Society for Medical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38777726","citation_count":65,"is_preprint":false},{"pmid":"15629926","id":"PMC_15629926","title":"Caulobacter crescentus requires RodA and MreB for stalk synthesis and prevention of ectopic pole formation.","date":"2005","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/15629926","citation_count":65,"is_preprint":false},{"pmid":"22116936","id":"PMC_22116936","title":"Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesis.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22116936","citation_count":62,"is_preprint":false},{"pmid":"35817971","id":"PMC_35817971","title":"Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity.","date":"2022","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35817971","citation_count":61,"is_preprint":false},{"pmid":"24788313","id":"PMC_24788313","title":"A mutation in POLE predisposing to a multi-tumour phenotype.","date":"2014","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24788313","citation_count":59,"is_preprint":false},{"pmid":"32497495","id":"PMC_32497495","title":"POLE Mutation Spectra Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair Status.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32497495","citation_count":59,"is_preprint":false},{"pmid":"27894751","id":"PMC_27894751","title":"Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro.","date":"2016","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27894751","citation_count":59,"is_preprint":false},{"pmid":"34363023","id":"PMC_34363023","title":"POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34363023","citation_count":58,"is_preprint":false},{"pmid":"31757464","id":"PMC_31757464","title":"Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.","date":"2019","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31757464","citation_count":58,"is_preprint":false},{"pmid":"18663358","id":"PMC_18663358","title":"Aurora-A and ch-TOG act in a common pathway in control of spindle pole integrity.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18663358","citation_count":52,"is_preprint":false},{"pmid":"30818169","id":"PMC_30818169","title":"POLE proofreading defects: Contributions to mutagenesis and cancer.","date":"2019","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/30818169","citation_count":51,"is_preprint":false},{"pmid":"20351295","id":"PMC_20351295","title":"Cell pole-specific activation of a critical bacterial cell cycle kinase.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20351295","citation_count":50,"is_preprint":false},{"pmid":"12828633","id":"PMC_12828633","title":"A lytic transglycosylase homologue, PleA, is required for the assembly of pili and the flagellum at the Caulobacter crescentus cell pole.","date":"2003","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12828633","citation_count":50,"is_preprint":false},{"pmid":"23046409","id":"PMC_23046409","title":"The cell pole: the site of cross talk between the DNA uptake and genetic recombination machinery.","date":"2012","source":"Critical reviews in biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23046409","citation_count":48,"is_preprint":false},{"pmid":"27244218","id":"PMC_27244218","title":"Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers.","date":"2016","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27244218","citation_count":48,"is_preprint":false},{"pmid":"25047610","id":"PMC_25047610","title":"Lessons from yeast: the spindle pole body and the centrosome.","date":"2014","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25047610","citation_count":47,"is_preprint":false},{"pmid":"35927456","id":"PMC_35927456","title":"A root phloem pole cell atlas reveals common transcriptional states in protophloem-adjacent cells.","date":"2022","source":"Nature plants","url":"https://pubmed.ncbi.nlm.nih.gov/35927456","citation_count":47,"is_preprint":false},{"pmid":"31673068","id":"PMC_31673068","title":"Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31673068","citation_count":46,"is_preprint":false},{"pmid":"23318641","id":"PMC_23318641","title":"pbx is required for pole and eye regeneration in planarians.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23318641","citation_count":45,"is_preprint":false},{"pmid":"29120461","id":"PMC_29120461","title":"Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.","date":"2017","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29120461","citation_count":44,"is_preprint":false},{"pmid":"28423643","id":"PMC_28423643","title":"POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28423643","citation_count":43,"is_preprint":false},{"pmid":"29072370","id":"PMC_29072370","title":"POLE somatic mutations in advanced colorectal cancer.","date":"2017","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29072370","citation_count":43,"is_preprint":false},{"pmid":"26251183","id":"PMC_26251183","title":"POLE mutations in families predisposed to cutaneous melanoma.","date":"2015","source":"Familial cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26251183","citation_count":42,"is_preprint":false},{"pmid":"17276919","id":"PMC_17276919","title":"Mechanisms of spindle-pole organization are influenced by kinetochore activity in mammalian cells.","date":"2007","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/17276919","citation_count":42,"is_preprint":false},{"pmid":"35927716","id":"PMC_35927716","title":"Yeast osmoregulation - glycerol still in pole position.","date":"2022","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/35927716","citation_count":41,"is_preprint":false},{"pmid":"34607897","id":"PMC_34607897","title":"Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors.","date":"2021","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34607897","citation_count":40,"is_preprint":false},{"pmid":"16339956","id":"PMC_16339956","title":"Characterization and spontaneous mutation of a novel gene, polE, involved in pellicle formation in Acetobacter tropicalis SKU1100.","date":"2005","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16339956","citation_count":40,"is_preprint":false},{"pmid":"29572003","id":"PMC_29572003","title":"Clinicopathological characteristics of POLE mutation in patients with non-small-cell lung cancer.","date":"2018","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/29572003","citation_count":39,"is_preprint":false},{"pmid":"26493165","id":"PMC_26493165","title":"GREM1 and POLE variants in hereditary colorectal cancer syndromes.","date":"2015","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26493165","citation_count":38,"is_preprint":false},{"pmid":"34338785","id":"PMC_34338785","title":"Pole position: How plant cells polarize along the axes.","date":"2022","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/34338785","citation_count":37,"is_preprint":false},{"pmid":"33715893","id":"PMC_33715893","title":"Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma.","date":"2021","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33715893","citation_count":36,"is_preprint":false},{"pmid":"26324921","id":"PMC_26324921","title":"PopZ identifies the new pole, and PodJ identifies the old pole during polar growth in Agrobacterium tumefaciens.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26324921","citation_count":36,"is_preprint":false},{"pmid":"10821171","id":"PMC_10821171","title":"A spindle pole body-associated protein, SNAD, affects septation and conidiation in Aspergillus nidulans.","date":"2000","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/10821171","citation_count":36,"is_preprint":false},{"pmid":"31974342","id":"PMC_31974342","title":"A biphasic growth model for cell pole elongation in mycobacteria.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31974342","citation_count":35,"is_preprint":false},{"pmid":"34531387","id":"PMC_34531387","title":"The biogeographic differentiation of algal microbiomes in the upper ocean from pole to pole.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34531387","citation_count":34,"is_preprint":false},{"pmid":"29659608","id":"PMC_29659608","title":"Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29659608","citation_count":33,"is_preprint":false},{"pmid":"24963130","id":"PMC_24963130","title":"The KASH protein Kms2 coordinates mitotic remodeling of the spindle pole body.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24963130","citation_count":32,"is_preprint":false},{"pmid":"15330869","id":"PMC_15330869","title":"nanos expression at the embryonic posterior pole and the medusa phase in the hydrozoan Podocoryne carnea.","date":"2004","source":"Evolution & development","url":"https://pubmed.ncbi.nlm.nih.gov/15330869","citation_count":32,"is_preprint":false},{"pmid":"26951196","id":"PMC_26951196","title":"Duplication of the Yeast Spindle Pole Body Once per Cell Cycle.","date":"2016","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26951196","citation_count":30,"is_preprint":false},{"pmid":"17878409","id":"PMC_17878409","title":"Dialogue between LKB1 and AMPK: a hot topic at the cellular pole.","date":"2007","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/17878409","citation_count":30,"is_preprint":false},{"pmid":"24472300","id":"PMC_24472300","title":"Frequent POLE1 p.S297F mutation in Chinese patients with ovarian endometrioid carcinoma.","date":"2014","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/24472300","citation_count":29,"is_preprint":false},{"pmid":"31240875","id":"PMC_31240875","title":"Clinicopathological and mutational analyses of colorectal cancer with mutations in the POLE gene.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31240875","citation_count":29,"is_preprint":false},{"pmid":"28883092","id":"PMC_28883092","title":"Human microcephaly ASPM protein is a spindle pole-focusing factor that functions redundantly with CDK5RAP2.","date":"2017","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/28883092","citation_count":28,"is_preprint":false},{"pmid":"25948378","id":"PMC_25948378","title":"A patient with polymerase E1 deficiency (POLE1): clinical features and overlap with DNA breakage/instability syndromes.","date":"2015","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25948378","citation_count":27,"is_preprint":false},{"pmid":"31624068","id":"PMC_31624068","title":"Germline POLE mutation in a child with hypermutated medulloblastoma and features of constitutional mismatch repair deficiency.","date":"2019","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/31624068","citation_count":27,"is_preprint":false},{"pmid":"39172836","id":"PMC_39172836","title":"Mechanisms of minor pole-mediated spindle bipolarization in human oocytes.","date":"2024","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/39172836","citation_count":26,"is_preprint":false},{"pmid":"29880869","id":"PMC_29880869","title":"Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29880869","citation_count":25,"is_preprint":false},{"pmid":"21179512","id":"PMC_21179512","title":"Targeting and anchoring Tudor in the pole plasm of the Drosophila oocyte.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21179512","citation_count":25,"is_preprint":false},{"pmid":"31479159","id":"PMC_31479159","title":"Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε (POLE).","date":"2019","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/31479159","citation_count":24,"is_preprint":false},{"pmid":"32627883","id":"PMC_32627883","title":"Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer.","date":"2020","source":"The oncologist","url":"https://pubmed.ncbi.nlm.nih.gov/32627883","citation_count":23,"is_preprint":false},{"pmid":"31495582","id":"PMC_31495582","title":"Centromere Dysfunction Compromises Mitotic Spindle Pole Integrity.","date":"2019","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/31495582","citation_count":22,"is_preprint":false},{"pmid":"31552169","id":"PMC_31552169","title":"Detection of POLE Subtypes in High-Grade Endometrioid Carcinoma by BaseScope-ISH Assay.","date":"2019","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31552169","citation_count":22,"is_preprint":false},{"pmid":"1617208","id":"PMC_1617208","title":"From egg to pole cells: ultrastructural aspects of early cleavage and germ cell determination in insects.","date":"1992","source":"Microscopy research and technique","url":"https://pubmed.ncbi.nlm.nih.gov/1617208","citation_count":21,"is_preprint":false},{"pmid":"37848928","id":"PMC_37848928","title":"Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1.","date":"2023","source":"Genome medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37848928","citation_count":20,"is_preprint":false},{"pmid":"31895686","id":"PMC_31895686","title":"CEP215 and AURKA regulate spindle pole focusing and aMTOC organization in mouse oocytes.","date":"2020","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31895686","citation_count":18,"is_preprint":false},{"pmid":"30194485","id":"PMC_30194485","title":"POLE gene hotspot mutations in advanced pancreatic cancer.","date":"2018","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30194485","citation_count":18,"is_preprint":false},{"pmid":"35020734","id":"PMC_35020734","title":"Analysis of HubP-dependent cell pole protein targeting in Vibrio cholerae uncovers novel motility regulators.","date":"2022","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35020734","citation_count":17,"is_preprint":false},{"pmid":"38463556","id":"PMC_38463556","title":"The Clinical and Pathological Characteristics of POLE-Mutated Endometrial Cancer: A Comprehensive Review.","date":"2024","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/38463556","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46460,"output_tokens":2939,"usd":0.091732,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10380,"output_tokens":3305,"usd":0.067263,"stage2_stop_reason":"end_turn"},"total_usd":0.158995,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"Germline heterozygous mutations in the proofreading (exonuclease) domain of POLE (p.Leu424Val) cause defective correction of mispaired bases inserted during DNA replication, leading to base substitution hypermutation in tumors. Yeast functional assays confirmed that these mutations impair exonuclease proofreading activity.\",\n      \"method\": \"Whole-genome sequencing, linkage/association analysis, yeast functional assays\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — yeast functional assays directly confirmed loss of proofreading activity; independently replicated across multiple families and labs\",\n      \"pmids\": [\"23263490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Somatic POLE exonuclease domain mutations cause an ultramutated phenotype in endometrial cancer characterized by C>A transversions and T>G substitutions, with microsatellite-stable tumors, resulting from defective proofreading of mispaired bases during DNA replication.\",\n      \"method\": \"Whole-exome sequencing, mutational signature analysis, genomic characterization of TCGA cohort\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — large genomic cohort with defined mutational signatures, single lab analysis but confirmed in independent TCGA dataset\",\n      \"pmids\": [\"25878334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"POLE exonuclease domain mutations at position p.Asn363Lys (located in the proofreading exonuclease domain) are directly involved in DNA binding; theoretical modeling predicted a profound effect on substrate binding capability and more severe impairment of catalytic activity compared to the p.Leu424Val mutation.\",\n      \"method\": \"Germline sequencing, in silico structural prediction, clinical phenotyping\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — mechanistic inference based primarily on computational prediction; no direct biochemical assay performed in this paper\",\n      \"pmids\": [\"24788313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"POLE exonuclease domain mutations generate an enriched repertoire of antigenic neoepitopes, which drives a robust intratumoral cytotoxic T-cell response (increased CD8+ TILs, upregulation of T-bet, Eomes, IFNG, PRF, granzyme B), explaining the favorable prognosis of POLE-ultramutated endometrial cancers.\",\n      \"method\": \"Immunohistochemistry for CD8+ TIL quantification, RNAseq analysis (TCGA), in silico neoepitope prediction\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — orthogonal methods (IHC, RNAseq, in silico neoepitope analysis) in single cohort with TCGA confirmation\",\n      \"pmids\": [\"25878334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Different POLE cancer mutant alleles drive distinct mutation spectra through differing degrees of replication fidelity impairment; unlike an exonuclease active-site mutant, POLE cancer mutants readily drive signature mutagenesis even in the presence of functional mismatch repair (MMR). The identity, abundance, and MMR status of the mutant allele shape the final mutation spectrum.\",\n      \"method\": \"CRISPR-Cas9 engineering of human cell lines expressing POLE tumor variants, whole-exome sequencing after defined population doublings\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct CRISPR-engineered cell lines with quantitative mutation accumulation analysis; multiple POLE alleles compared with and without MMR\",\n      \"pmids\": [\"32497495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A POLE germline mutation p.Tyr458Phe, located in the active site of the exonuclease domain, affects a residue important for exonuclease activity. Functional assays in S. pombe demonstrated increased DNA mutation rate comparable to a Pol ε mutant lacking exonuclease activity entirely.\",\n      \"method\": \"Exome sequencing, S. pombe functional mutation rate assays\",\n      \"journal\": \"Familial cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vivo yeast functional assay directly measuring mutation rate, but single lab, single variant\",\n      \"pmids\": [\"25860647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A POLE germline mutation p.Trp347Cys in the exonuclease domain leads to an increased DNA mutation rate in S. pombe functional assays, comparable to that seen with a Pol ε mutant with no exonuclease activity.\",\n      \"method\": \"S. pombe functional assays measuring mutation rate\",\n      \"journal\": \"Familial cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct yeast functional assay, single lab, single variant tested\",\n      \"pmids\": [\"26251183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A POLE variant c.1420G>A (p.Val474Ile) outside the canonical exonuclease domain was shown by functional assays in Schizosaccharomyces pombe to impair proofreading activity, broadening the spectrum of POLE changes that can lead to mutator phenotype.\",\n      \"method\": \"S. pombe functional mutation rate assays, bioinformatics prediction\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct yeast functional assay performed, single lab, single variant\",\n      \"pmids\": [\"28423643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Murine syngeneic tumors harboring functional Pole mutations displayed enhanced antitumor immunity and sensitivity to immune checkpoint blockade. Pathogenic POLE/POLD1 mutations generate neoantigens with increased hydrophobicity at TCR-contact residues, potentially facilitating T-cell recognition. The spectrum of mutational signatures (not merely mutation presence) correlates with the biochemical features of neoantigens and predicts ICB response.\",\n      \"method\": \"Murine syngeneic tumor models with Pole mutations, mutational signature analysis, neoantigen biochemical feature analysis, clinical ICB outcome correlation\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — orthogonal experimental (mouse tumor models) and correlative patient data with mechanistic neoantigen analysis; replicated across cohorts\",\n      \"pmids\": [\"35817971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"POLE exonuclease domain mutation (ultramutated EC) primary cell lines are significantly more resistant to platinum-based chemotherapy in vitro compared to POLE wild-type EC cell lines, suggesting that favorable prognosis of POLE-mutated tumors is not secondary to chemosensitivity but to enhanced immunogenicity.\",\n      \"method\": \"Primary tumor cell line establishment, in vitro platinum drug sensitivity assays\",\n      \"journal\": \"Gynecologic oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vitro drug sensitivity assay in primary cell lines, single lab\",\n      \"pmids\": [\"27894751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A patient with POLE1 deficiency (homozygous splice variant c.4444+3A>G in the POLE1 gene encoding the catalytic subunit of DNA polymerase epsilon) manifested a severe chromosome instability syndrome with growth retardation, microcephaly, developmental delay, immune deficiency, and myelodysplasia, demonstrating that loss of POLE1 catalytic function causes a DNA instability phenotype in humans.\",\n      \"method\": \"Exome sequencing, clinical phenotyping of POLE1-deficient patient\",\n      \"journal\": \"BMC medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — human loss-of-function variant with defined clinical phenotype, single case report\",\n      \"pmids\": [\"25948378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Loss-of-function and outside-exonuclease-domain variants in POLE are likely not pathogenic for polymerase proofreading-associated cancer syndrome, whereas missense variants within the exonuclease domain that impair proofreading are the relevant pathogenic class. This was supported by cosegregation, case-control studies, and yeast-based functional assays.\",\n      \"method\": \"Multigene panel sequencing, yeast functional assays, cosegregation and case-control studies\",\n      \"journal\": \"Genetics in medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — yeast functional assays plus clinical genetic evidence; multi-variant analysis in large cohort\",\n      \"pmids\": [\"32792570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Pathogenic POLE exonuclease domain mutations (EDMs) produce a characteristic genomic signature: C>A substitutions >20%, T>G substitutions >4%, C>G substitutions <0.6%, indels <5%, and TMB >100 mut/Mb. Co-existence of pathogenic POLE EDM with MSI-H still produces POLE-characteristic genomic alterations, demonstrating that the POLE proofreading defect dominates the mutational phenotype.\",\n      \"method\": \"Whole-exome sequencing, genomic signature analysis, mutational burden analysis (TCGA cohort and independent cohort)\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic genomic characterization of 82 ECs with multiple orthogonal genomic metrics; confirmed in pooled analysis\",\n      \"pmids\": [\"31829442\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLE (DNA polymerase epsilon catalytic subunit, POLE1) encodes the catalytic and proofreading subunit of DNA polymerase epsilon; missense mutations within its exonuclease (proofreading) domain impair correction of mispaired bases during DNA replication, causing extreme base-substitution hypermutation with a characteristic mutational signature (C>A, T>G enrichment), which in turn generates abundant neoantigens that elicit robust cytotoxic T-cell responses and sensitize tumors to immune checkpoint blockade, while different mutant alleles vary in their degree of replication fidelity impairment and interact with mismatch repair status to shape the final mutation burden and spectrum.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"POLE encodes the catalytic and proofreading subunit of DNA polymerase epsilon, whose exonuclease (proofreading) domain corrects mispaired bases inserted during DNA replication; germline and somatic missense mutations in this domain impair proofreading and produce base-substitution hypermutation in tumors [#0, #1]. Yeast functional assays directly confirm that such exonuclease-domain variants (e.g., p.Leu424Val, p.Trp347Cys, p.Tyr458Phe) raise mutation rates to levels comparable with complete loss of exonuclease activity, while non-exonuclease and loss-of-function variants do not cause the proofreading-associated cancer phenotype [#0, #5, #6, #11]. The resulting genomic signature is highly characteristic — enrichment of C>A transversions and T>G substitutions with very high tumor mutational burden — and this proofreading defect dominates the mutational phenotype even when mismatch repair is concurrently defective [#1, #4, #12]. Different POLE mutant alleles drive distinct mutation spectra according to their degree of fidelity impairment, and cancer-associated mutants generate signature mutagenesis even in the presence of functional mismatch repair [#4]. The hypermutator phenotype generates an enriched repertoire of antigenic neoepitopes that elicits a robust intratumoral cytotoxic CD8+ T-cell response and confers sensitivity to immune checkpoint blockade [#3, #8]. Complete loss of POLE catalytic function causes a distinct chromosome-instability syndrome with growth retardation, microcephaly, immune deficiency, and myelodysplasia [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 2012,\n      \"claim\": \"Established that germline mutations in the POLE proofreading domain are causal for base-substitution hypermutation, linking a specific molecular defect to a cancer-predisposition phenotype.\",\n      \"evidence\": \"Whole-genome sequencing with linkage/association analysis and yeast functional assays of p.Leu424Val\",\n      \"pmids\": [\"23263490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the quantitative mutation rate of individual alleles\", \"Did not address somatic versus germline contribution to tumor burden\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Predicted that distinct exonuclease-domain residues contribute to DNA/substrate binding and that different variants impair catalysis to differing degrees.\",\n      \"evidence\": \"Germline sequencing with in silico structural modeling of p.Asn363Lys\",\n      \"pmids\": [\"24788313\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct biochemical assay performed; computational prediction only\", \"Predicted differential severity not experimentally validated\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the somatic ultramutated genomic phenotype of POLE-mutant endometrial cancer and connected it to enhanced immunogenicity and favorable prognosis via neoepitope-driven cytotoxic T-cell responses.\",\n      \"evidence\": \"Whole-exome and mutational signature analysis, IHC for CD8+ TILs, and RNAseq in a TCGA cohort with in silico neoepitope prediction\",\n      \"pmids\": [\"25878334\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Neoepitope immunogenicity inferred in silico, not functionally validated\", \"Causal link between T-cell response and outcome correlative\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Directly measured that specific exonuclease-domain germline variants (p.Tyr458Phe, p.Trp347Cys) raise mutation rates to levels comparable to complete exonuclease loss, validating their pathogenicity functionally.\",\n      \"evidence\": \"S. pombe functional mutation-rate assays of individual variants\",\n      \"pmids\": [\"25860647\", \"26251183\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-variant, single-lab assays\", \"Yeast mutation rate may not fully reproduce human tumor spectrum\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated that POLE-mutant tumor cells are resistant to platinum chemotherapy, establishing that favorable prognosis derives from immunogenicity rather than chemosensitivity.\",\n      \"evidence\": \"Primary tumor cell line establishment with in vitro platinum sensitivity assays\",\n      \"pmids\": [\"27894751\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab in vitro assay\", \"Did not test in vivo chemotherapy response\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed that complete loss of POLE catalytic function in humans causes a chromosome-instability/immunodeficiency syndrome distinct from the proofreading-associated cancer phenotype.\",\n      \"evidence\": \"Exome sequencing and clinical phenotyping of a homozygous splice-variant patient\",\n      \"pmids\": [\"25948378\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single case report\", \"Mechanistic basis of multisystem phenotype not dissected\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended the pathogenic variant spectrum by showing a variant outside the canonical exonuclease domain can also impair proofreading.\",\n      \"evidence\": \"S. pombe functional mutation-rate assays of p.Val474Ile\",\n      \"pmids\": [\"28423643\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single variant, single lab\", \"Structural basis of proofreading impairment outside the domain unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Resolved allele-specific behavior, showing that cancer POLE mutants drive signature mutagenesis even with functional mismatch repair, and that allele identity, abundance, and MMR status shape the final spectrum.\",\n      \"evidence\": \"CRISPR-Cas9 engineering of human cell lines expressing POLE tumor variants with whole-exome sequencing after defined population doublings\",\n      \"pmids\": [\"32497495\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Limited set of alleles tested\", \"Quantitative contribution of each factor to clinical spectrum not modeled\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Clarified which variant classes are pathogenic, establishing that exonuclease-domain missense variants impairing proofreading—not loss-of-function or out-of-domain variants—drive the cancer syndrome.\",\n      \"evidence\": \"Multigene panel sequencing with yeast functional assays, cosegregation and case-control studies\",\n      \"pmids\": [\"32792570\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Some intermediate variants of uncertain significance remain unclassified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Quantified a robust diagnostic genomic signature and showed the POLE proofreading defect dominates even when co-occurring with MSI-H.\",\n      \"evidence\": \"Whole-exome and genomic signature/TMB analysis of endometrial cancer cohorts\",\n      \"pmids\": [\"31829442\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Thresholds derived from limited cohort\", \"Generalizability across tumor types not fully tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Provided in vivo causal evidence that POLE-driven mutagenesis enhances antitumor immunity and ICB sensitivity, and linked neoantigen biochemical features (hydrophobicity at TCR-contact residues) and signature spectrum to immune response.\",\n      \"evidence\": \"Murine syngeneic tumor models with Pole mutations, neoantigen biochemical feature analysis, and clinical ICB outcome correlation\",\n      \"pmids\": [\"35817971\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal contribution of specific neoantigens to ICB response not isolated\", \"Predictive value of signature spectrum requires prospective validation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How POLE assembles into and functions within the holoenzyme replication complex, and the structural basis by which individual exonuclease-domain residues control proofreading fidelity, remain uncharacterized in this corpus.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of mutant proofreading defects\", \"Holoenzyme partner interactions not addressed in the timeline\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 4, 5, 6, 7]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 5, 6]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0, 11]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 10, 12]}\n    ],\n    \"complexes\": [\"DNA polymerase epsilon\"],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}